Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-30 · accession 0000950170-24-088589 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-31 | 2024-07-30 | KPTI | Poulton Stuart | EVP, Chief Development Off | S - Sale | $1.06 | -2,883 | 326.6K | -0.9% | -$3,056 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-30 | S | D | 2,883 | $1.06 | 326,628 | D | — | — |